First Page | Document Content | |
---|---|---|
Date: 2007-07-09 08:23:20Satraplatin Johnson Matthey Chemistry GPC Biotech HRPC | Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory CommitteeAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 27,25 KBShare Document on Facebook |